Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

After large drops during the pandemic, life expectancy in the United States should recover to 2019 levels this year ...

In a year of pivotal gastroenterology research, these 10 articles were in a class of their own, according to Dr David Johnson ...

The river was swift and unrelenting, its currents carrying victim after victim downstream. Local villagers responded by ...

The FDA has granted approval for its first medication for certain patients with sleep apnea—the weight-loss drug Zepbound.

GII Innovation announced on the 20th that its board of directors has resolved to issue 11,644,800 shares through a ...

For the first time, placental genes were studied to explore how Assisted Reproductive Technology (ART) affects a child’s ...

Donald Trump has bullied and bluffed his way through boardrooms, backrooms, newsrooms, courtrooms and even the White House ...

Sermo queried more than 1,150 healthcare providers for the latest edition of its “Barometer” report and found that nearly 80% ...

A vision-threatening eye condition may be linked to Ozempic. Meanwhile, Nearly 80% of doctors are using telemedicine weekly, ...

Eli Lilly and Novo Nordisk will kick off a massive shopping spree in 2025. The two obesity giants will be sitting on cash ...

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...